75
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Postoperative Adjuvant Transarterial Chemoembolization Improves Short-Term Prognosis of Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Propensity-Score Matching Study

, ORCID Icon, ORCID Icon, , , , & ORCID Icon show all
Pages 9183-9195 | Published online: 28 Sep 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kongying Lin, Fuqun Wei, Qizhen Huang, Zisen Lai, Jinyu Zhang, Qingjing Chen, Yabin Jiang, Jie Kong, Shichuan Tang, Jianhuai Lin, Yufeng Chen, Jinhong Chen & Yongyi Zeng. (2022) Postoperative Adjuvant Transarterial Chemoembolization Plus Tyrosine Kinase Inhibitor for Hepatocellular Carcinoma: a Multicentre Retrospective Study. Journal of Hepatocellular Carcinoma 9, pages 127-140.
Read now

Articles from other publishers (4)

Guo-Ying Feng, Zheng-Rong Shi, Yu-Fei Zhao, Kai Chen, Jie Tao, Xu-Fu Wei & Yu Cheng. (2023) Therapeutic effect of postoperative adjuvant transcatheter arterial chemoembolization based on the neutrophil-to-lymphocyte ratio. Frontiers in Surgery 9.
Crossref
Yan-Jun Xiang, Ju-Xian Sun, Jia-Yi Wu, Kang Wang, Jin-Kai Feng, Yong-Gang Wei, Jian-Yin Zhou, Zhi-Bo Zhang, Yu-Qing Zhang, Ying-Yi Qin, Mao-Lin Yan & Shu-Qun Cheng. (2022) Recurrence hazard rate in patients with hepatocellular carcinoma and bile duct tumor thrombus: a multicenter observational study. HPB 24:10, pages 1703-1710.
Crossref
Zong-Han Liu, Ju-Xian Sun, Jin-Kai Feng, Shi-Ye Yang, Zhen-Hua Chen, Chang Liu, Zong-Tao Chai, Fei-Fei Mao, Wei-Xing Guo, Jie Shi & Shu-Qun Cheng. (2022) Prognostic Comparison Between Liver Resection and Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Patients With Bile Duct Tumor Thrombus: A Propensity-Score Matching Analysis. Frontiers in Oncology 12.
Crossref
Kongying Lin, Qizhen Huang, Lei Wang, Jianxing Zeng, Zongren Ding, Hongzhi Liu, Jun Fu, Pengfei Guo, Zhenwei Chen, Yongyi Zeng, Weiping Zhou & Jingfeng Liu. (2021) Pre- and Postoperative Models for Prediction of Recurrence in Non-B, Non-C Hepatocellular Carcinoma. Frontiers in Oncology 11.
Crossref